Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibitionGabrielle S. Wong, Adam J. Bass, David Xu et al.|Nature Medicine|2018Cited by 282
Impact of certification status of the institute and surgeon on short-term outcomes after surgery for thoracic esophageal cancer: evaluation using data on 16,752 patients from the National Clinical Database in JapanSatoru Motoyama, Hisahiro Matsubara, Hiroyuki Yamamoto et al.|Esophagus|2019Cited by 60
Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibitionGabrielle S. Wong, Adam J. Bass, Jin Zhou et al.|Nature Medicine|2018Cited by 10